blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2358373

EP2358373 - INJECTABLE POLYDEOXYRIBONUCLEOTIDE COMPOSITION FOR THE TREATMENT OF OSTEOARTICULAR DISEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.07.2016
Database last updated on 19.10.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Mastelli S.r.l.
Via Bussana Vecchia 32
18038 Sanremo (IM) / IT
[2014/42]
Former [2011/34]For all designated states
Medevice S.P.A.
Via Cernaia 31
10121 Torino / IT
Inventor(s)01 / CATTARINI MASTELLI, Laura
Piazza Farini 1
I-18018 Taggia (Imperia) / IT
02 / CATTARINI MASTELLI, Giulia
Via G. Mameli 7/5
I-16122 Genova / IT
 [2011/34]
Representative(s)Rambelli, Paolo, et al
Jacobacci & Partners S.p.A.
Corso Emilia 8
10152 Torino / IT
[2015/37]
Former [2011/34]Rambelli, Paolo, et al
Jacobacci & Partners S.p.A. Corso Emilia 8
10152 Torino / IT
Application number, filing date09764046.028.10.2009
[2011/34]
WO2009IB54776
Priority number, dateIT2008TO0080430.10.2008         Original published format: IT TO20080804
[2011/34]
Filing languageIT
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010049898
Date:06.05.2010
Language:EN
[2010/18]
Type: A1 Application with search report 
No.:EP2358373
Date:24.08.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 06.05.2010 takes the place of the publication of the European patent application.
[2011/34]
Type: B1 Patent specification 
No.:EP2358373
Date:09.09.2015
Language:EN
[2015/37]
Search report(s)International search report - published on:EP06.05.2010
ClassificationIPC:A61K31/711, A61K31/713, A61P19/02
[2011/34]
CPC:
A61K35/60 (EP,US); A61K31/711 (EP,US); A61K31/713 (EP,US);
A61P19/02 (EP); A61P29/00 (EP)
C-Set:
A61K31/711, A61K2300/00 (EP,US);
A61K31/713, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2015/37]
Former [2011/34]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:INJIZIERBARE POLYDESOXYRIBONUKLEOTIDZUSAMMENSETZUNG ZUR BEHANDLUNG OSTEOARTIKULÄRER KRANKHEITEN[2011/34]
English:INJECTABLE POLYDEOXYRIBONUCLEOTIDE COMPOSITION FOR THE TREATMENT OF OSTEOARTICULAR DISEASES[2011/34]
French:COMPOSITION DE POLYDÉSOXYRIBONUCLÉOTIDE INJECTABLE POUR LE TRAITEMENT DE MALADIES OSTÉOARTICULAIRES[2011/34]
Entry into regional phase30.05.2011National basic fee paid 
30.05.2011Designation fee(s) paid 
30.05.2011Examination fee paid 
Examination procedure30.05.2011Amendment by applicant (claims and/or description)
30.05.2011Examination requested  [2011/34]
27.03.2015Communication of intention to grant the patent
30.07.2015Fee for grant paid
30.07.2015Fee for publishing/printing paid
30.07.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.03.2015
Opposition(s)10.06.2016No opposition filed within time limit [2016/33]
Fees paidRenewal fee
23.08.2011Renewal fee patent year 03
24.08.2012Renewal fee patent year 04
30.10.2013Renewal fee patent year 05
22.08.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.10.2009
BE09.09.2015
BG09.09.2015
CY09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
IT09.09.2015
LT09.09.2015
LV09.09.2015
MC09.09.2015
MK09.09.2015
MT09.09.2015
RO09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
SM09.09.2015
IE28.10.2015
LU28.10.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
[2018/30]
Former [2018/02]HU28.10.2009
BE09.09.2015
BG09.09.2015
CY09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
IT09.09.2015
LT09.09.2015
LV09.09.2015
MC09.09.2015
MT09.09.2015
RO09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
SM09.09.2015
IE28.10.2015
LU28.10.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
Former [2017/38]HU28.10.2009
BE09.09.2015
BG09.09.2015
CY09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
IT09.09.2015
LT09.09.2015
LV09.09.2015
MC09.09.2015
MT09.09.2015
RO09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
SM09.09.2015
IE28.10.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
Former [2017/03]BE09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
IT09.09.2015
LT09.09.2015
LV09.09.2015
MC09.09.2015
RO09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
IE28.10.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
Former [2016/45]EE09.09.2015
FI09.09.2015
HR09.09.2015
IT09.09.2015
LT09.09.2015
LV09.09.2015
MC09.09.2015
RO09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
IE28.10.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
Former [2016/36]EE09.09.2015
FI09.09.2015
HR09.09.2015
IT09.09.2015
LT09.09.2015
LV09.09.2015
MC09.09.2015
RO09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
Former [2016/28]EE09.09.2015
FI09.09.2015
HR09.09.2015
IT09.09.2015
LT09.09.2015
LV09.09.2015
MC09.09.2015
RO09.09.2015
SE09.09.2015
SK09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
Former [2016/23]EE09.09.2015
FI09.09.2015
HR09.09.2015
IT09.09.2015
LT09.09.2015
LV09.09.2015
RO09.09.2015
SE09.09.2015
SK09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
Former [2016/22]EE09.09.2015
FI09.09.2015
HR09.09.2015
IT09.09.2015
LT09.09.2015
LV09.09.2015
SE09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
Former [2016/21]FI09.09.2015
HR09.09.2015
IT09.09.2015
LT09.09.2015
LV09.09.2015
SE09.09.2015
NO09.12.2015
GR10.12.2015
Former [2016/11]FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
SE09.09.2015
NO09.12.2015
GR10.12.2015
Former [2016/09]FI09.09.2015
LT09.09.2015
LV09.09.2015
NO09.12.2015
GR10.12.2015
Former [2016/08]LT09.09.2015
NO09.12.2015
Former [2016/07]LT09.09.2015
Cited inInternational search[Y]WO0173003  (BIOCELL LAB [US], et al) [Y] 1-8 * page 14; example 4.1; claims 1,14,24 *;
 [Y]WO03035048  (NOVARTIS AG [CH], et al) [Y] 1-8 * pages 16,41; claims 2,6,24 *;
 [AD]FR2676926  (FLECCHIA PIERRE [FR]) [AD] 1-8 * page 6 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.